Literature DB >> 26651150

Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.

Isabel Ruiz-Zamora1, Jorge Rodriguez-Capitan2, Alicia Guerrero-Molina3, Luis Morcillo-Hidalgo3, Isabel Rodriguez-Bailon4, Juan Jose Gomez-Doblas4, Eduardo de Teresa-Galvan4, Jose Manuel Garcia-Pinilla5.   

Abstract

BACKGROUND: Left ventricular reverse remodeling (LVRR) in dilated cardiomyopathy is poorly known within the context of current therapeutic approach. Our goal is to describe the present incidence of LVRR, the factors able to predict it and the long term prognosis of these patients. METHODS AND
RESULTS: We performed a retrospective analysis of a cohort or 387 consecutive outpatients. Mean follow-up was 50.4 ± 28.4 months. Sustained LVRR occurred in 57.6% of patients. The number of coronary arteries with severe stenosis (HR 0.69, 95% CI 0.55-0.86; p=0.001), New York Heart Association Functional Class (NYHA FC) (HR 0.39, 95% CI 0.27-0.54; p<0.001) as well as the severity of mitral regurgitation (MR) at the end of follow-up (HR 0.42, 95% CI 0.30-0.58; p<0.001) and the time until first event (HR 1.02, 95% CI 1.01-1.03; p<0.001) were independent predictors of left ventricular ejection fraction improvement. LVRR was tightly related to prognosis due to the fact that both improvement in cardiac function achieving normal or slightly impaired LVEF (HR 0.31, 95% CI 0.17-0.56; p<0.001) and shorter time to achieve LVRR (HR 0.99, 95% CI 0.98-0.99; p=0.017) formed part of the best model for predicting events in DCM.
CONCLUSION: More than half of the patients showed sustained LVRR associated with a significantly better prognosis. Fewer numbers of coronary arteries with severe stenosis, milder NYHA FC and the absence of significant MR at the end of follow-up as well as longer event free period formed a simple model to prognosticate LVRR. LVRR and the time to achieve it were strongly related to long term prognosis in patients with DCM.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dilated cardiomyopathy; Prognosis; Reverse remodeling; Ventricle

Mesh:

Year:  2015        PMID: 26651150     DOI: 10.1016/j.ijcard.2015.11.099

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.

Authors:  Arthur Cescau; Lucas N L Van Aelst; Mathilde Baudet; Alain Cohen Solal; Damien Logeart
Journal:  ESC Heart Fail       Date:  2017-07-27

2.  Role of blocking ADAM10 hydrolysis site on N-cadherin by single-chain antibody in ventricular remodeling.

Authors:  Xiaoou Li; Wei Huang; Bing He; Lirong Zhou; Xiaogang Huang; Baozhen Yao
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

Review 3.  Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments.

Authors:  Nicoletta Orphanou; Efstathios Papatheodorou; Aris Anastasakis
Journal:  Heart Fail Rev       Date:  2021-07-14       Impact factor: 4.654

4.  Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.

Authors:  Carles Díez-López; Joel Salazar-Mendiguchía; Elena García-Romero; Lara Fuentes; Josep Lupón; Antoni Bayés-Genis; Nicolás Manito; Marta de Antonio; Pedro Moliner; Elisabet Zamora; Pablo Catalá-Ruiz; Miguel Caínzos-Achirica; Josep Comín-Colet; José González-Costello
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.